With providing smooth medical treatment, China has requisitioned medical supplies production across the country as millions struggle to obtain basic drugs and testing kits in the face of a surge in Covid-19 cases.

Pharmacies in major cities have been stripped bare in the wake of the Chinese government’s sudden decision to lift years of lockdowns, quarantines and mass testing, meanwhile.

Authorities have urged those with mild symptoms to stay at home and take treatment into their own hands, leading to a run on everything from ibuprofen to rapid antigen tests.

To address nationwide shortages, more than a dozen Chinese pharmaceutical firms have been tapped by officials to help “secure supplies” of key drugs — a euphemism for requisitioning — according to AFP interviews and local media.

At least 11 of 42 test kit makers whose products are licensed by China’s medical regulators have had part of their production seized by the government or received orders from the state, local reports said.

Wiz Biotech, a rapid antigen test maker in the southern city of Xiamen, confirmed to AFP on Thursday that all kits they produce will be requisitioned by the local government.

In Beijing, authorities have sent additional staff to six manufacturers of antigen kits to help them “increase production”, the municipality said on its website.